Gregory Kaufman

Title: Gregory Kaufman: Innovator in Pharmaceutical Solutions

Introduction

Gregory Kaufman is a notable inventor based in Short Hills, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of trichomoniasis and vitamin B12 deficiency. With a total of 2 patents, Kaufman's work reflects his commitment to advancing medical science.

Latest Patents

Kaufman's latest patents include a method and pharmaceutical composition for treating or preventing trichomoniasis. This innovative method involves administering a therapeutically effective amount of secnidazole or a pharmaceutically acceptable salt in a microgranule formulation. The formulation is designed to address various conditions, including bacterial vaginosis and metronidazole-resistant trichomoniasis. Additionally, Kaufman has developed methods and compositions for cyclical provision of a vitamin B12 compound. This invention aims to prevent or treat vitamin B12 deficiency, particularly in individuals experiencing periodic physiological challenges.

Career Highlights

Throughout his career, Kaufman has worked with prominent companies such as Evofem Biosciences, Inc. and Lupin, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Kaufman has collaborated with notable professionals in the field, including Richard John Holl and James Garegnani. These partnerships have further enhanced his contributions to pharmaceutical research and development.

Conclusion

Gregory Kaufman's innovative work in pharmaceuticals showcases his dedication to improving health outcomes through targeted treatments. His patents reflect a deep understanding of medical needs and a commitment to advancing therapeutic solutions.